FDA clears Alabama university's depression device

06/9/2010 | American City Business Journals

The FDA has given the green light to the University of Alabama, Birmingham, to use its Repetitive Transcranial Magnetic Stimulation device for the treatment of patients who have failed to respond to antidepressant drugs. The rTMS device works by delivering MRI-strength magnetic pulses to the brain.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC